M2 Tissue, Cell, and Gene Biotherapies (BTCG)
The aim of the master 2 in Biotherapy Tissular Cellular and Genic (BTCG) is to provide students from different initial training with solid foundations in fundamental research but also to offer varied openings to the professional world of Health. This master offers through two specialties (research or professional) skills applicable to the field of biotherapies, which covers gene therapies, cell therapies, immunotherapy and innovative pharmacotherapies
Cite and evaluate specific tools and animal models used in biotherapies.
Semester 1
Students choose between two specialties: research or professional. The common basis has 10 European credits (ECTS) and each subspeciality 20 ECTS. Lectures are in English except Industry and corporate life and Clinical research in biotherapies in French.
Semester 2
•A 6–months training takes place in academic laboratories or biotechnology, pharmarceutical companies located on site or abroad, in Europe, North America, .. It gives right to 30 ECTS
- Biotechnology, research and development in industry, academic research, scientific communication and popularisation, medicine, pharmacy, veterinary medicine.
- Research positions and clinical applications in the medical and surgical fields, positions in the pharmaceutical and veterinary fields that relate to the development and evaluation of biotherapy protocols.
- Positions related to medicine in the pharmaceutical industry, French or European health agencies, biotechnology industries.
- Senior executive positions in industry, biotechnology companies, regulatory agencies, research organisations
Master 1 level or equivalent with basics in cellular and molecular biology
Semester 2
•A 6–months training takes place in academic laboratories or biotechnology, pharmarceutical companies located on site or abroad, in Europe, North America, .. It gives right to 30 ECTS
oui
After this Master's programme, successful students may either pursue a PhD or follow a professional career in research and development in pharmaceutical or biotechnology industry and acamedic laboratory. Students from the professional option often integrate an ARC (Attaché de Recherche Clinique) training course or join industry in a engineering position.
Approches génétiques intégrées et découvertes thérapeutiques pour les maladies rares
Biologie du Développement et Reproduction
Biomarqueurs en cancérologie et onco-hématologie
Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie
Biomolécules : Conception, Isolement, Synthèse
Centre de Recherche en épidémiologie et Santé des populations
Centre de recherche en Immunologie des infections virales et des maladies autoimmunes - DRF/JACOB
Centre de Nanosciences et de Nanotechnologies
Centre National de Recherche en Génomique Humaine - DRF/JACOB
Département Médicaments et technologies pour la santé - DRF/JOLIOT
Genoscope - DRF/JACOB
Hématopoièse Normale et Pathologique
Immunologie des tumeurs et Immunothérapie
Infection et inflammation Chronique
Institut des Cellules souches pour le traitement et l'étude des maladies monogéniques
Institut des maladies émergentes et des thérapies nouvelles - DRF/JACOB
Institut Paris Saclay d'Innovation thérapeutique
Institute for Integrative Biology of the Cell - DRF/JOLIOT
Interactions Cellules souches-niches: physiologie, tumeurs et réparation tissulaire
Laboratoire des Maladies Neurodégénératives : mécanismes, thérapies, imagerie - DRF/JACOB/MIRCen.
The schedule will be posted shortly.
-
Motivation letter.
-
All transcripts of the years / semesters validated since the high school diploma at the date of application.
-
Curriculum Vitae.
-
The application procedure, which depends on your nationality and your situation is explained here : https://urlz.fr/i3Lo.
-
Certificate of English level (compulsory for non-English speakers).
-
VAP file (obligatory for all persons requesting a valuation of the assets to enter the diploma).
-
Supporting documents :
- Residence permit stating the country of residence of the first country
- Or receipt of request stating the country of first asylum
- Or document from the UNHCR granting refugee status
- Or receipt of refugee status request delivered in France
- Or residence permit stating the refugee status delivered in France
- Or document stating subsidiary protection in France or abroad
- Or document stating temporary protection in France or abroad.